Nexalin Technology (NXL) Non Operating Investment Income (2023 - 2026)
Nexalin Technology (NXL) recorded quarterly Non Operating Investment Income of $88.0 in Q1 2026, down 91.52% quarter-over-quarter from $1038.0 in Q4 2025, and down 89.4% on a YoY basis from $830.0 in Q1 2025.
Nexalin Technology (NXL) Non Operating Investment Income (2023 - 2026) Analysis & Trends
Nexalin Technology's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at $88.0 for Q1 2026.
- In Q1 2026, Non Operating Investment Income fell 89.4% year-over-year to $88.0; the TTM figure through Mar 2026 stood at $178.0 (down 68.33% YoY), while the FY2025 annual figure was $919.0, up 950.93% from the prior year.
- Non Operating Investment Income was $88.0 for Q1 2026 at Nexalin Technology, down from $1038.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $41069.0 in Q1 2023 to a low of -$32289.0 in Q3 2023.
- Historically, Non Operating Investment Income has averaged $38.08 across 4 years, with a median of $88.0 in 2026.
- Biggest YoY gain for Non Operating Investment Income was 652.13% in 2025; the steepest drop was 349.54% in 2025.
- A 4-year view of Non Operating Investment Income shows it stood at -$1205.0 in 2023, then soared by 84.4% to -$188.0 in 2024, then jumped by 652.13% to $1038.0 in 2025, then tumbled by 91.52% to $88.0 in 2026.
- The last three Non Operating Investment Income figures came in at $88.0 (Q1 2026), $1038.0 (Q4 2025), and -$1461.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Nexalin Technology | 8.72 Mn | 6.01 Mn | 13,133.00 | 88.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.00 |
| Mar 31, 2026 | 88.00 |
| Dec 31, 2025 | 1,038.00 |
| Dec 31, 2025 | 1,038.00 |
| Sep 30, 2025 | -1,461.00 |
| Sep 30, 2025 | -1,461.00 |
| Jun 30, 2025 | 513.00 |
| Jun 30, 2025 | 513.00 |
| Mar 31, 2025 | 830.00 |
| Mar 31, 2025 | 830.00 |
| Dec 31, 2024 | -188.00 |
| Dec 31, 2024 | -188.00 |
| Sep 30, 2024 | -325.00 |
| Sep 30, 2024 | -325.00 |
| Jun 30, 2024 | 245.00 |
| Jun 30, 2024 | 245.00 |
| Mar 31, 2024 | 160.00 |
| Mar 31, 2024 | 160.00 |
| Dec 31, 2023 | -1,205.00 |
| Dec 31, 2023 | -1,205.00 |